Bioprocessing, Inc. Completes New Biomanufacturing Facility Move.PORTLAND, Maine Portland is the largest city in the U.S. state of Maine, with a 2004 population of 63,882. Portland is Maine's cultural, social and economic capital. Tourists are drawn to Portland's historic Old Port district along Portland Harbor, which is at the mouth of the Fore River and part -- Bioprocessing, Inc. announced today that it has recently moved into a new bulk biologics manufacturing facility in Portland, Maine. Construction began in December of 2005 and the facility and is now operationally complete.. Operations at the site have an initial workforce of 13 employees. The facility contains five cell culture suites that enable Bioprocessing, Inc. to expand from its previous facility in Scarborough, Maine Scarborough is a town in Cumberland County on the southern coast of Maine. It is located about 7 miles (10 km) south of Portland. Since 1969, the town has had a Council-manager government. . The new manufacturing facility supports a five fold increased production capacity for its bioreactor bioreactor a container in which living organisms carry out a biological reaction. produced products and services. "The ability to expand our cell culture expertise is key in our participation in the development and manufacture of new biomarkers and preclinical biologics" said Gary Goodrich, President of Bioprocessing, Inc. "This new facility is a vital part of our commitment to provide critical tumor marker tumor marker n. A substance, released into the circulation by tumor tissue, whose detection in the serum indicates the presence of a specific type of tumor. raw material products and services to the diagnostic, research and biopharmaceutical industries. We are particularly excited about operating an eco-friendly and highly energy efficient building. A low environmental impact and a safe, comfortable workplace are important parts of our company goals." Privately owned and operated, Bioprocessing, Inc. was established in 1991 as a diagnostic reagent manufacturer. It has steadily grown from a company providing tumor marker proteins, its core niche area of expertise, to one, which provides hybridoma hybridoma /hy·brid·o·ma/ (hi?brid-o´mah) a somatic cell hybrid formed by fusion of normal lymphocytes and tumor cells. hy·brid·o·ma n. development and manufacturing services for producing monoclonal antibodies This is a list of monoclonal antibodies, antibodies which are clones of a single parent cell. When used as medications, the generic names end in -mab (see "Nomenclature of monoclonal antibodies"). and recombinant proteins Since human recombinants have replaced the animal version in human therapeutics, the prefix of "rh" for "human recombinant" appears less and less in the literature Human recombinants that replaced animal or harvested from human types "We have tried to make our new building a reflection of our technology," said Goodrich. "Highly efficient and state of the art." Contact: Conrad Maurais 1045 Riverside Street Portland, ME 04103 Telephone: 207-457-0025 Fax: 207-457-0027 Email: info@bioprocessinginc.com Website: www.bioprocessinginc.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion